1-4 of 4
Julia Glade-Bender, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Dose Finding Study of Panobinostat in Children with Hematologic Malignancies: Initial Report of TACL Study T2009-012 in Children with Acute Leukemia

John M Goldberg, MD, Julia Glade-Bender, MD, Maria Luisa Sulis, MD, Rebecca A Gardner, MD, Jessica A. Pollard, MD, Victor Aquino, MD, Naomi J. Winick, MD, Bruce C. Bostrom, MD, Cecilia Fu, MD, Raymond J. Hutchinson, MD, Thomas J. Manley, MD, Rajen Mody, MD MS, Javier Oesterheld, MD, Blythe Thomson, MD, Julie R Park, MD, Jeannette Cassar, Elena Eckroth, CCRC, Richard Sposto, PhD, Yoav H Messinger, MD, Nobuko HiJiya, MD, Paul S Gaynon, MD, Julio C. Barredo, MD
Journal: Blood
Blood (2014) 124 (21): 3705.
https://doi.org/10.1182/blood.V124.21.3705.3705
Published: 2014
Journal Articles

Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium

Michael J. Burke, MD, Patrick Brown, MD, Lia Gore, MD, Richard Sposto, PhD, Deepa Bhojwani, Bill H Chang, MD PhD, Steven G. Dubois, MD, Paul S Gaynon, MD, Julia Glade-Bender, MD, Kenneth Matthew Heym, MD, Maria Luisa Sulis, MD, Jessica A. Pollard, MD, Anupam Verma, MD, Van Huynh, MD
Journal: Blood
Blood (2014) 124 (21): 3650.
https://doi.org/10.1182/blood.V124.21.3650.3650
Published: 2014
Journal Articles

Reduced-Toxicity (RTC) Versus Myeloablative Conditioning (MAC) Prior to Allogeneic Stem Cell Transplantation in Pediatric Participants: Significant Improvement in Physical Functioning Following RTC Versus MAC

Jennifer A Oberg, EdD, Erin Morris, RN, Lauren Harrison, RN, MSN, Julia Glade Bender, MD, James H Garvin, Jr., MD, PhD, Stephen Sands, PsyD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2011) 118 (21): 2069.
https://doi.org/10.1182/blood.V118.21.2069.2069
Published: 2011
Journal Articles

Remarkable Activity of Bortezomib Combined with Chemotherapy in a Phase I Study of Relapsed Childhood Acute Lymphoblastic Leukemia (ALL). A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Yoav H. Messinger, MD, Paul S. Gaynon, MD, Elizabeth Raetz, MD, Raymond Hutchinson, MD, MS, Steven DuBois, MD, Julia Glade Bender, MD, Richard Sposto, PhD, Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Bruce C. Bostrom, MD
Journal: Blood
Blood (2008) 112 (11): 1919.
https://doi.org/10.1182/blood.V112.11.1919.1919
Published: 2008